JERECZEK, BARBARA ALICJA
 Distribuzione geografica
Continente #
EU - Europa 33.991
AS - Asia 21.588
NA - Nord America 19.835
SA - Sud America 2.393
AF - Africa 587
OC - Oceania 152
Continente sconosciuto - Info sul continente non disponibili 17
Totale 78.563
Nazione #
US - Stati Uniti d'America 19.153
DE - Germania 16.415
SG - Singapore 6.674
CN - Cina 6.185
IT - Italia 4.580
GB - Regno Unito 4.403
HK - Hong Kong 2.236
RU - Federazione Russa 2.118
VN - Vietnam 1.858
BR - Brasile 1.788
SE - Svezia 1.591
FR - Francia 1.365
IN - India 993
BD - Bangladesh 985
IE - Irlanda 731
NL - Olanda 699
TR - Turchia 637
FI - Finlandia 505
KR - Corea 495
CA - Canada 425
ID - Indonesia 370
UA - Ucraina 366
JP - Giappone 327
ES - Italia 211
AR - Argentina 198
PL - Polonia 192
EU - Europa 183
CI - Costa d'Avorio 181
DK - Danimarca 175
PH - Filippine 139
AU - Australia 133
AT - Austria 130
MX - Messico 110
MA - Marocco 108
EC - Ecuador 103
IQ - Iraq 101
CO - Colombia 99
ZA - Sudafrica 91
CH - Svizzera 88
BE - Belgio 86
PK - Pakistan 75
CL - Cile 64
TW - Taiwan 53
PT - Portogallo 51
GR - Grecia 49
VE - Venezuela 47
TH - Thailandia 43
MY - Malesia 42
EG - Egitto 39
KE - Kenya 38
PE - Perù 38
TN - Tunisia 38
IR - Iran 36
CZ - Repubblica Ceca 34
SA - Arabia Saudita 34
NP - Nepal 33
AE - Emirati Arabi Uniti 32
JO - Giordania 31
RO - Romania 31
UZ - Uzbekistan 31
CR - Costa Rica 29
AZ - Azerbaigian 23
IL - Israele 23
NG - Nigeria 23
NO - Norvegia 21
PY - Paraguay 21
HU - Ungheria 20
HN - Honduras 18
KZ - Kazakistan 18
UY - Uruguay 18
AL - Albania 17
JM - Giamaica 17
NZ - Nuova Zelanda 17
DO - Repubblica Dominicana 15
DZ - Algeria 15
GT - Guatemala 15
LT - Lituania 15
OM - Oman 15
BG - Bulgaria 14
BO - Bolivia 13
LU - Lussemburgo 13
PA - Panama 12
KG - Kirghizistan 11
KW - Kuwait 11
LB - Libano 11
SV - El Salvador 11
SK - Slovacchia (Repubblica Slovacca) 10
SY - Repubblica araba siriana 10
TT - Trinidad e Tobago 10
GE - Georgia 9
RS - Serbia 9
IS - Islanda 8
AO - Angola 7
BY - Bielorussia 7
LK - Sri Lanka 7
SC - Seychelles 7
EE - Estonia 6
ET - Etiopia 6
MM - Myanmar 6
HR - Croazia 5
Totale 78.609
Città #
Frankfurt am Main 15.137
Southend 3.797
Singapore 3.742
Ashburn 2.289
Hong Kong 2.000
San Jose 1.632
Milan 1.429
Chandler 1.324
Dallas 1.111
Beijing 982
Princeton 815
Council Bluffs 793
Seattle 762
Dublin 710
Los Angeles 662
Wilmington 608
New York 539
Ho Chi Minh City 533
Lauterbourg 460
Santa Clara 444
Bengaluru 427
Hanoi 417
Fairfield 411
Hefei 407
Buffalo 350
Moscow 342
Guangzhou 291
Nanjing 271
Rome 266
Des Moines 262
Houston 260
Redmond 242
Jakarta 239
Dearborn 238
Shanghai 228
Woodbridge 216
Cambridge 213
Jacksonville 204
Helsinki 203
Munich 200
Mountain View 198
Toronto 196
São Paulo 190
Tokyo 186
Phoenix 183
Abidjan 181
Ann Arbor 166
Columbus 164
Cangzhou 163
Jinan 162
Sakarya 148
Boardman 143
Istanbul 138
Redwood City 134
Tianjin 132
Seoul 122
Nuremberg 119
Shenyang 117
Berlin 113
Hyderabad 102
Chicago 98
Warsaw 97
The Dalles 96
Naples 94
Florence 91
Grafing 90
Da Nang 87
Turin 86
Haiphong 85
Shenzhen 85
Changsha 83
Nanchang 78
Dong Ket 77
London 77
Mumbai 75
Atlanta 72
Hangzhou 72
Bogotá 68
Andover 65
Brussels 64
Medford 64
Paris 64
Washington 62
Boston 60
Eitensheim 59
Montreal 59
Hebei 58
Casablanca 57
San Diego 57
Bologna 56
Turku 56
Madrid 55
Vienna 55
Rio de Janeiro 54
Orem 52
Fuzhou 48
Central District 46
Johannesburg 46
Serra 46
Silver Spring 46
Totale 51.253
Nome #
Salvage stereotactic body radiotherapy for local prostate cancer recurrence after radiotherapy: a retrospective multicentre study of the GETUG 1.183
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 467
Association of quantitative mri-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma 430
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients 416
Whole-body magnetic resonance imaging: Technique, guidelines and key applications 390
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 387
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 387
Linee guida carcinoma della prostata : AIRO, 2016 382
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment 373
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) : inter-observer agreement between readers of different expertise levels 358
Adjuvant radiotherapy treatment for soft tissue sarcoma of extremities and trunk. A retrospective mono-institutional analysis 339
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 338
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 328
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 327
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy 319
STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia) : rationale and design of an Italian experimental prospective study 318
Automatic Segmentation with Deep Learning in Radiotherapy 315
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy 309
Effects of sex and age on fat fraction, diffusion-weighted image signal intensity and apparent diffusion coefficient in the bone marrow of asymptomatic individuals: A cross-sectional whole-body mri study 306
Artificial Intelligence for Medicine : An Applied Reference for Methods and Applications 305
Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer 301
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 293
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 290
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 289
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 289
[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy 288
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 287
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300) 284
High-performance prediction models for prostate cancer radiomics 283
MR imaging for selection of patients for partial breast irradiation : a systematic review and meta-analysis 279
Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study 277
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach 276
Head and neck cancer radiotherapy amid COVID‐19 pandemic : Report from Milan, Italy 273
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 267
Clinical risk analysis of the patient’s path in an Advanced Radiotherapy Center (A.R.C.) through F.M.E.A. method 264
Low Dose Rate Brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy : Practice and outcome analysis in a series of 2237 patients from 11 Institutions 263
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 263
The QUBIC instrument for CMB polarization measurements 261
Late toxicity of image-guided hypofractionated radiotherapy for prostate : non-randomized comparison with conventional fractionation 257
Robot-assisted radical prostatectomy : multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins 257
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 257
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips 255
High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study 255
COVID-19 outbreak and cancer radiotherapy disruption in Italy : Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 254
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series 253
Tossicità con radioterapia e brachiterapia 249
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy 248
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 248
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 247
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 245
Impact of a dedicated radiologist as a member of the head and neck tumour board : a single-institution experience 244
Mixup (Sample Pairing) Can Improve the Performance of Deep Segmentation Networks 244
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors 243
Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients 242
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 241
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 240
Recent radiomics advancements in breast cancer: Lessons and pitfalls for the next future 240
Recent advances in radiation oncology 239
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction 239
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast 238
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion : ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218 236
Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib/II study 236
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 234
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 232
Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy 232
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 232
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience 230
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 230
Value of perfusion CT parameters, microvessl density and VEGF expression in differentiation of benign and malignant prostate tumours 228
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study 227
Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients 226
Machine Learning for Head and Neck Cancer: A Safe Bet?—A Clinically Oriented Systematic Review for the Radiation Oncologist 225
PROACTA: a survey on the actual attitude of the Italian radiation oncologists in the management and prescription of hormonal therapy in prostate cancer patients 225
Oral Surgery and Osteoradionecrosis in Patients Undergoing Head and Neck Radiation Therapy: An Update of the Current Literature 224
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 224
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL 223
COMBINED SURGERY AND POST-OPERATIVE RADIOTHERAPY OR CHEMORADIOTHERAPY FOR LOCALLY ADVANCED TONGUE CANCER 222
Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy 222
Quality assurance for automatically generated contours with additional deep learning 220
Adjuvant and salvage radiation therapy after prostatectomy : investigating beliefs and practices of radiation oncologists 220
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 217
Virtual and Augmented Reality as a Novel Opportunity to Unleash the Power of Radiotherapy in the Digital Era: A Scoping Review 214
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation 214
Hypofractionated proton therapy in breast cancer: where are we? A critical review of the literature 214
Stereotactic Radiotherapy Ablation and Atrial Fibrillation: Technical Issues and Clinical Expectations Derived From a Systematic Review 214
Influence of different urinary bladder filling levels and controlling regions of interest selection on deformable image registration algorithms 213
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 213
A qualitative investigation on patient empowerment in prostate cancer 212
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases 211
Prognostic significance of neutrophil‐to‐lymphocyte ratio in HPV status era for oropharyngeal cancer 211
Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study 210
Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier 210
Long-Term Results and Reconstruction Failure in Patients Receiving Postmastectomy Radiation Therapy with a Temporary Expander or Permanent Implant in Place 210
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial 210
COVID-19 and radiotherapy: impact on work and personal life of Lombardy residents during first lockdown, survey endorsed by AIRO Young 210
Almost one year of COVID-19 pandemic : how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 209
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients 208
Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy : a consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM) 207
Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation? 207
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence : A Multi-institutional Analysis 206
Totale 27.207
Categoria #
all - tutte 205.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.929


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021939 0 0 0 0 0 0 0 0 0 0 602 337
2021/20224.110 167 139 135 163 258 301 266 269 379 447 377 1.209
2022/20236.043 741 571 511 639 511 1.088 223 401 647 119 400 192
2023/202414.288 193 308 335 255 956 523 2.251 1.992 986 1.920 2.269 2.300
2024/202515.738 2.158 2.230 1.758 1.566 813 511 363 1.149 667 1.008 1.188 2.327
2025/202626.097 2.514 1.881 2.852 2.305 2.254 1.561 3.698 1.365 2.883 1.744 3.040 0
Totale 81.704